2026 Optometrist Report
Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.
New Content
Ocular Surface Disease in 2026: What Every Optometry Student Should Know
Mapping the Premium IOL Patient Journey: From Evaluation to Long-Term Satisfaction
The Ultimate Guide to Interventional Glaucoma with the Glaukos Portfolio
Interventional glaucoma is a treatment approach for managing ocular hypertension and various stages of glaucoma. Join Drs. Shah, Ristvedt, Micheletti, Funke, and Yadgarov as they discuss the available treatment options and how this new approach is influencing glaucoma management.
The Role of Tear Film Biomarkers in Diagnosing and Managing DED
Sit down with Drs. Damon Dierker and Jerry Robben to review how to interpret and integrate tear film biomarkers into dry eye disease management workflows.
Geographic Atrophy: Why Early Detection is the New Standard of Care
How clinical data from the past three years have shifted the treatment landscape and reformed the clinical calculus when it comes to managing geographic atrophy patients.
Topics
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
Systems That Keep Patients Buying Lenses In-House
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
2026 Contact Lens Report
Download the free report to learn how optometrists are managing their contact lens practices in 2026!
Warby Parker introduces first Intelligent Eyewear frame collection
Developed in partnership with Google and Samsung, the customizable frames include prescription-based lenses, embedded Gemini, and an HDR camera.
Novartis reports positive phase 3 data on ianalumab for Sjögren’s
NEPTUNUS trials demonstrate reduced disease activity with no new safety signals; Novartis anticipates FDA decision later this year.
Tenpoint introduces YUVEZZI telehealth prescribing program
New program offers eligible patients a virtual option for prescription fills of the first and only FDA-approved dual-agent eye drop approved for adults presbyopia.
i-Lumen reports new i-SIGHT data on retinal bioelectric stimulation for dry AMD
Ocular Surface Disease in 2026: What Every Optometry Student Should Know
Consider current and pipeline ocular surface disease therapies that optometrists can integrate or anticipate in the coming months, and download the cheat sheet!
EyesUp - Ocular Surface Edition
Play along with the game EyesUp to learn more about immunomodulators for the treatment of DED.
Mapping the Premium IOL Patient Journey: From Evaluation to Long-Term Satisfaction
Join Drs. McCabe and Donnenfeld as they discuss how to connect evaluation, patient education, surgery, and follow-up into a cohesive cataract surgery journey.
Clinical Specialties
The Role of Tear Film Biomarkers in Diagnosing and Managing DED
Geographic Atrophy: Why Early Detection is the New Standard of Care
Systems That Keep Patients Buying Lenses In-House
Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.
2026 Optometrist Report
Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.
Careers
How I Made CareCredit Simple for My Team and Patients
The Impact of Presbyopia Drops on Optical Sales
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
Featured Writers
Become a WriterThe Ultimate Guide to Interventional Glaucoma with the Glaukos Portfolio
Interventional glaucoma is a treatment approach for managing ocular hypertension and various stages of glaucoma. Join Drs. Shah, Ristvedt, Micheletti, Funke, and Yadgarov as they discuss the available treatment options and how this new approach is influencing glaucoma management.
